The idea of treating disease by replacing a defective gene with a working copy gained credence in 1990 with the success of the world's first gene therapy clinical tests against a rare condition called severe combined immunodeficiency (SCID).

MSN: European regulators back first gene therapy drug

Last month, the European Union approved Glybera for treatment of a rare genetic disease, making it the first gene-therapy medicine approved in the Western world.

WSJ: The Future of Medicine Is Now: Medical Innovations

Neither fusion inhibitors nor immune therapy are likely to make much impact in the developing world, simply because of cost.

BBC: Aids: The medical progress

Glaxo started a rare disease unit recently and in a press call today said it was licensing a gene therapy for a disease that hits just 350 kids in the world.

FORBES: Glaxo Brings Gene Therapy Back From The Dead

When he needed integrated therapy with his retinal detachment and his lymphoma, he could have a world-class retina doctor seeing him at the same time.

FORBES

Dr. WEINER: Around the world there are certainly many women who have been on tamoxifen for five years, have been off all therapy for a few years, and might consider going on a drug like letrozole or specifically letrozole based on these results.

NPR: Study: Drug Can Curb Breast Cancer Recurrence